Quarterly report pursuant to Section 13 or 15(d)

Segment Information

v3.21.2
Segment Information
9 Months Ended
May 31, 2021
Segment Information  
18. Segment Information

 

 

18.

Segment Information

 

 

 

The Company’s operations involve the development and usage, including licensing, of its proprietary DehydraTECH Technology. Lexaria is centrally managed and its chief operating decision makers, being the president and the CEO, use the consolidated and other financial information supplemented by revenue information by category of alternative health consumer products and technology licensing to make operational decisions and to assess the performance of the Company. The Company has identified two reportable segments: Intellectual Property and Products. Licensing revenues are significantly concentrated on one licensee.

 

 

IP Licensing
$

 

 

Products
$

 

 

Corporate
$

 

 

Consolidated Total
$

 

Revenue

 

 

326,474

 

 

 

360,658

 

 

 

4,585

 

 

 

691,717

 

Cost of goods sold

 

 

-

 

 

 

(155,037 )

 

 

-

 

 

 

(155,037 )

Operating expenses

 

 

914,485

 

 

 

(402,846 )

 

 

(3,909,802 )

 

 

(3,398,163 )

Discontinued operations

 

 

(22,000 )

 

 

-

 

 

 

-

 

 

 

(22,000 )

Segment income(loss)

 

 

1,218,959

 

 

 

(197,225 )

 

 

(3,905,217 )

 

 

(2,883,483 )

Total assets

 

 

709,155

 

 

 

51,738

 

 

 

9,786,659

 

 

 

10,547,553

 

 

Capital Asset by Region

 

Cost
US

 

 

Disposal US

 

 

Net Balance
US

 

 

Cost
Canada

 

 

Net Balance Canada

 

 

Total Net Balance

 

Nine Months Ended May 31, 2021

 

$

 

 

 $

 

 

$

 

 

 $

 

 

$

 

 

 $

 

Leasehold Improvements

 

 

-

 

 

 

-

 

 

 

-

 

 

 

259,981

 

 

 

132,843

 

 

 

132,843

 

Computers

 

 

-

 

 

 

-

 

 

 

-

 

 

 

63,964

 

 

 

17,334

 

 

 

17,334

 

Furniture Fixtures Equipment

 

 

3,094

 

 

 

3,094

 

 

 

-

 

 

 

31,126

 

 

 

16,309

 

 

 

16,310

 

Lab Equipment

 

 

98,050

 

 

 

-

 

 

 

71,899

 

 

 

193,185

 

 

 

157,010

 

 

 

228,910

 

 

 

 

101,144

 

 

 

3,094

 

 

 

71,899

 

 

 

548,256

 

 

 

323,496

 

 

 

395,397

 

 

Capital Asset by Region

 

Cost
US

 

 

Net Balance
US

 

 

Cost
Canada

 

 

Net Balance Canada

 

 

Total Net Balance

 

Year Ended August 31, 2020

 

 $

 

 

 $

 

 

$

 

 

$

 

 

$

 

Leasehold Improvements

 

 

-

 

 

 

-

 

 

 

259,981

 

 

 

173,371

 

 

 

173,371

 

Computers

 

 

-

 

 

 

-

 

 

 

63,964

 

 

 

32,095

 

 

 

32,095

 

Furniture Fixtures Equipment

 

 

3,094

 

 

 

-

 

 

 

31,126

 

 

 

21,123

 

 

 

21,123

 

Lab Equipment

 

 

98,050

 

 

 

85,263

 

 

 

193,185

 

 

 

171,505

 

 

 

256,768

 

 

 

 

101,144

 

 

 

85,263

 

 

 

548,256

 

 

 

398,094

 

 

 

483,357